Synlett 2004(2): 0326-0328  
DOI: 10.1055/s-2003-43368
LETTER
© Georg Thieme Verlag Stuttgart · New York

Asymmetric PTC Alkylation of Glycine Imines: Variation of the Imine Ester Moiety

Barry Lygo*, Bryan Allbutt
School of Chemistry, University of Nottingham, Nottingham, NG7 2RD, UK
e-Mail: B.Lygo@Nottingham.ac.uk;
Further Information

Publication History

Received 9 September 2003
Publication Date:
26 November 2003 (online)

Abstract

Studies into the enantioselective phase-transfer alkylation of a series of glycine imine esters are presented. Using a quaternary ammonium salt catalyst derived from α-methyl-naphthylamine, high enantioselectivities were obtained in reactions involving imines containing tert-butyl, benzhydryl, and benzyl esters. In contrast, a quaternary ammonium salt catalyst derived from dihydrocinchonidine gave highest enantioselectivities with tert-butyl and ethyl esters. Application of the benzhydryl ester alkylation in the preparation of a differentially protected aspartic acid derivative is also presented.

    References

  • For recent reviews covering phase-transfer alkylation of glycine imines see:
  • 1a Maruoka K. Ooi T. Chem. Rev.  2003,  103:  3013 
  • 1b O’Donnell MJ. Aldrichimica Acta  2001,  34:  3 
  • 2a Lygo B. Allbutt B. James SR. Tetrahedron Lett.  2003,  44:  5629 
  • 2b Lygo B. Andrews BI. Crosby J. Peterson JA. Tetrahedron Lett.  2002,  43:  8015 
  • 2c Lygo B. Humphreys LD. Tetrahedron Lett.  2002,  43:  6677 
  • 2d Lygo B. Crosby J. Peterson JA. Tetrahedron  2001,  57:  6447 
  • 2e Lygo B. Crosby J. Lowdon TR. Peterson JA. Wainwright PG. Tetrahedron  2001,  57:  2403 
  • 2f Lygo B. Crosby J. Lowdon TR. Wainwright PG. Tetrahedron  2001,  57:  2391 
  • 2g Lygo B. Crosby J. Peterson JA. Tetrahedron Lett.  1999,  40:  1385 
  • 2h Lygo B. Wainwright PG. Tetrahedron Lett.  1997,  38:  8595 
  • For examples of asymmetric PTC alkylation of glycine imines other than tert-butyl ester 1a see ref. 1 and:
  • 3a Ooi T. Tayama E. Maruoka K. Angew. Chem. Int. Ed.  2003,  42:  579 ; amides
  • 3b Mazon P. Chinchilla R. Najera C. Guillena G. Kreiter R. Gebbink . R JMK. van Koten G. Tetrahedron: Asymmetry  2002,  13:  2181 ; iso-propyl ester
  • 3c Vyskocil S. Meca L. Tislerova I. Cisarova I. Polasek M. Harutyunyan SR. Belokon YN. Stead RMJ. Farrugia L. Lockhart SC. Mitchell WL. Kocovsky P. Chem.-Eur. J.  2002,  8:  4633 ; Ni salt of PBP imine
  • For leading references to asymmetric PTC alkylations of glycine imine1a not covered in ref.1 and ref.2, see:
  • 4a Ooi T. Kameda M. Maruoka K. J. Am. Chem. Soc.  2003,  125:  5139 
  • 4b Mase N. Ohno T. Hoshikawa N. Ohishi K. Morimoto H. Yoda H. Takabe K. Tetrahedron Lett.  2003,  44:  4073 
  • 4c Park HG. Jeong BS. Yoo MS. Lee JH. Park BS. Kim MJ. Jew SS. Tetrahedron Lett.  2003,  44:  3497 
  • 4d Thierry B. Plaquevent JC. Cahard D. Tetrahedron: Asymmetry  2003,  14:  1671 
  • 4e Danelli T. Annunziata R. Benaglia M. Cinquini M. Cozzi F. Tocco G. Tetrahedron: Asymmetry  2003,  14:  461 
  • 4f Okino T. Takemoto Y. Org. Lett.  2001,  3:  1515 
  • 4g Chen G. Deng Y. Gong L. Mi A. Cui X. Jiang Y. Choi MCK. Chan ASC. Tetrahedron: Asymmetry  2001,  12:  1567 
  • 4h O’Donnell MJ. Delgado F. Dominguez E. de Blas J. Scott WL. Tetrahedron: Asymmetry  2001,  12:  821 
  • See for example ref.4a and:
  • 5a Kim S. Lee J. Lee T. Park HG. Kim D. Org. Lett.  2003,  5:  2703 
  • 5b Armstrong A. Scutt JN. Org. Lett.  2003,  5:  2331 
  • 5c Lygo B. Andrews BI. Tetrahedron Lett.  2003,  44:  4499 
  • 5d Boisnard S. Carbonnelle A.-C. Zhu J. Org. Lett.  2001,  3:  2061 
  • 5e Lygo B. Tetrahedron Lett.  1999,  40:  1389 
  • 6 O’Donnell MJ. Polt RL. J. Org. Chem.  1982,  47:  2663 
  • For examples that illustrate of the utility of this see:
  • 7a Mitchell SA. Pratt MR. Hruby VJ. Polt R. J. Org. Chem.  2001,  66:  2327 
  • 7b Tilley JW. Sarabu R. Wagner R. Mulkerins K. J. Org. Chem.  1990,  55:  906 
  • 7c Felix AM. Heimer EP. Lambros TJ. Tzougraki C. Meienhofer J. J. Org. Chem.  1978,  43:  4194 
  • 8 O’Donnell MJ. Sennett WD. Wu S. J. Am. Chem. Soc.  1989,  111:  2353 
  • 10 Corey EJ. Xu F. Noe MC. J. Am. Chem. Soc.  1997,  119:  12414 
9

Representative Procedure: A solution of salt ent-4 (1.2 mg, 1 mol%) and imine 1b (50 mg, 0.12 mmol) in toluene (4 mL) was cooled to 0 °C, degassed, and placed under an argon atmosphere. tert-Butyl bromoacetate (22 µL, 0.14 mmol) was added followed by degassed 15 M aq KOH (1mL). The resulting mixture stirred at 1500 rpm for 45 min, then diluted with H2O (5 mL) and extracted with EtOAc (3 × 4 mL). The combined organic extracts were dried (MgSO4) and concentrated under reduced pressure. Residual tert-butyl bromoacetate was removed under vacuum (1 mm Hg, r.t.) to afford imine 2b′′′ as a colourless oil (64 mg, 100%, 86% ee). 1H NMR (400 MHz, CDCl3): δ = 7.62-7.60 (2 H, m, ArH), 7.41-7.23 (16 H, m, ArH), 7.16-7.13 (2 H, m, ArH), 6.89 (1 H, s, OCHPh2), 4.58 (1 H, dd, J = 7.5, 5.5 Hz, H-2), 2.99 (1 H, dd, J = 15.5, 5.5 Hz, H-3a), 2.85 (1 H, dd, J = 15.5, 7.5 Hz, H-3b), 1.35 (9H, s, t-Bu). 13C NMR (100 MHz, CDCl3): δ = 171.8 (C), 170.0 (C), 139.9 (C), 139.9 (C), 139.6 (C), 136.0 (C), 130.5 (CH), 129.0 (CH), 128.8 (CH), 128.5 (CH), 128.0 (CH), 128.0 (CH), 127.9 (CH), 127.4 (CH), 127.1 (CH), 80.8 (C), 77.5 (CH), 62.3 (CH), 39.5 (CH2), 28.1 (CH3). HPLC: Chiralpak AD column (150 × 2.1 mm), hexane/i-propanol (97.5/2.5), 0.2 mL/min, Rt = 13.9 min (R)-isomer, 18.8 min (S)-isomer.
Imine 2b′′′ (38 mg) was then dissolved in THF (1 mL) and treated with 15% aq citric acid (1 mL). The resulting solution was stirred at r.t. for 3 h, then washed with Et2O (3 × 2 mL). The aqueous layer was basified (sat. aq K2CO3) and extracted with CHCl3 (3 × 5 mL). The combined organic extracts were dried (MgSO4) and concentrated under reduced pressure to afford amine 5 as a colourless oil (22 mg, 85%). 1H NMR (400 MHz, CDCl3): δ = 7.36-7.27 (10 H, m, ArH), 6.92 (1 H, s, OCHPh2), 3.84 (1 H, dd, J = 6.5, 4.5 Hz, H-2), 2.80 (1 H, dd, J = 16.5, 4.5 Hz, H-3a), 2.72
(1 H, dd, J = 16.5, 6.5 Hz, H-3b), 1.88 (2 H, s, broad, NH2), 1.38 (9 H, s, t-Bu). 13C NMR (100 MHz, CDCl3): δ = 173.5 (C), 170.3 (C), 139.8 (C), 128.6 (CH), 128.6 (CH), 128.2 (CH), 128.1 (CH), 127.2 (CH), 127.2 (CH), 81.5 (C), 77.8 (CH), 51.6 (CH), 39.8 (CH2), 28.1 (CH3)